]>
IRCT2016110830776N1 IRCT 2017-03-16 The Research Center of Neurology Diseases, Kerman University of Medical Sciences The effect of Sofoofe Banafshe on migraines The effect of traditional medicine product Sofoofe Banafshe on the prevention of headaches in patients with migraine 2016-10-24 anticipated 86 Complete https://irct.ir/trial/24350 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Prevention, Other design features: Randomized double-blind study using four glass blocks. 2-3 migraine. Intervention 1: Patients in the control group receiving propranolol 20 mg twice daily plus placebo capsules 500 mg three times a day. Intervention 2: Patients in the intervention group receiving propranolol 20 mg twice daily plus Sofoofe Banafshe capsuls 500 mg three times a day.
public Mohadese Kamali
The Pardis of Traditional Medicine, Modiriat street
Kerman Iran (Islamic Republic of) +98 34 3312 2020 mohadesekamali0912@gmail.com Kerman University of Medical Sciences, School of Traditional Medicine scientific Mohadese Kamali
The Pardis of traditional medicine, Modiriat street
Kerman Iran (Islamic Republic of) +98 34 3312 2020 mohadesekamali0912@gmail.com Kerman University of Medical Sciences, School of Traditional Medicine Iran (Islamic Republic of) Inclusion criteria: confirmed the diagnosis of migraine according to the criteria of IHS; 15-45 age range; patients' awareness of their disease, no pregnancy or lactation, without any other chronic diseases (heart, thyroid, hepatic, renal, neurologic, hypertension, diabetes, depression, etc.), experiencing at least four migraine attacks per month in the past few months Exclusion criteria: dislike continuing cooperation, deciding for pregnancy or having a positive pregnancy test, experiencing non-migraine headaches; non-compliance with prescribed medication 80 years 50 years Both G43 Use additional external cause code (Chapter XX), if desired, to identify drug, if drug-induced. Treatment - Drugs Treatment - Drugs Patients in the control group receiving propranolol 20 mg twice daily plus placebo capsules 500 mg three times a day Patients in the intervention group receiving propranolol 20 mg twice daily plus Sofoofe Banafshe capsuls 500 mg three times a day The number of migraine attacks per week. Timepoint: Two weeks and one month after intervention. Method of measurement: Self made questionnaire. Severity of headache. Timepoint: Two weeks and one month after intervention. Method of measurement: VAS. Freqency of headaches. Timepoint: Two weeks and one month after intervention. Method of measurement: Self made questionnaire. Quality of life. Timepoint: Two weeks and one month after intervention. Method of measurement: SF36. The Research Center of Neurology Diseases, Kerman University of Medical Sciences Approved 2016-10-24 Kerman University of Medical Sciences The Pardis of Kerman University of Medical Sciences, Haft bagh Boulevard, Kerman Kerman Iran (Islamic Republic of)